Company profile for Enyo Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ENYO Pharma is a clinical stage Biotech with a unique drug discovery engine inspired by viruses. The company is currently entering Phase 2 with its lead compound EYP001 (a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreove...
ENYO Pharma is a clinical stage Biotech with a unique drug discovery engine inspired by viruses. The company is currently entering Phase 2 with its lead compound EYP001 (a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreover be developed for various indications

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
Bâtiment Domilyon 321 avenue Jean Jaurès 69007 LYON, FRANCE
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250612279577/en/ENYO-Pharma-Announces-Completion-of-Series-C-Financing-With-Vesalius-Biocapital-and-Continued-Progress-of-Its-ALPESTRIA-1-Clinical-Phase-2-Study-in-Alport-Syndrome-Patients

BUSINESSWIRE
12 Jun 2025

https://www.businesswire.com/news/home/20211103005709/en

BUSINESSWIRE
03 Nov 2021

https://www.businesswire.com/news/home/20210730005079/en

BUSINESS WIRE
30 Jul 2021

https://www.businesswire.com/news/home/20210728005557/en

BUSINESSWIRE
29 Jul 2021
Enyo Pharma notches a mid-stage trial win in tricky NASH
Enyo Pharma notches a mid-stage trial win in tricky NASH

28 Jul 2021

// Annalee Armstrong FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/enyo-pharma-s-nash-results-show-boost-kidney-function-differentiating-vonafexor-from-busy

Annalee Armstrong FIERCEBIOTECH
28 Jul 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty